Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
Studies revealing the real-world impact of disruptions to the US President’s Emergency Plan for AIDS Relief (PEPFAR) and important advances in long-acting HIV prevention and treatment were announced ...
SurvivorNet on MSN
A simpler delivery system: FDA approves subcutaneous injection version of powerful targeted drug isatuximab for multiple myeloma
A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...
Morning Overview on MSN
The FDA cleared a once-a-week Alzheimer’s shot that patients can give themselves at home
People living with early Alzheimer’s disease can now begin treatment with Leqembi without setting foot in an infusion center.
According to Carney, who was present for his birth, Tornado was the biggest puppy of the litter and has lived up to his name ...
When Sanofi won FDA approval in July 2026 for the first anticancer treatment administered with an on-body injector (OBI), the Enable Injections enFuse platform made it possible. The enFuse OBI secured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results